Tissue inhibitor of metalloproteinases 1 (TIMP1) serves as an early detection and prognosis biomarker for aggressive lung cancer—its serum level correlates with tumor burden and survival in mice, and has been validated in clinical samples [14]. Here, TIMP1 is linked to lung cancer.